Alnylam Pharmaceuticals

$231.66

-$0.34 (-0.15%) As of 5:15 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. is a global commercial-stage biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. Its products include ONPATTRO, GIVLAARI, and OXLUMO.

CEO

Yvonne L. Greenstreet

CEOYvonne L. Greenstreet

Employees

1,665

Employees1,665

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2002

Founded2002

Employees

1,665

Employees1,665

ALNY Key Statistics

Market cap

27.81B

Market cap27.81B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

1.96M

Average volume1.96M

High today

$234.51

High today$234.51

Low today

$228.08

Low today$228.08

Open price

$231.90

Open price$231.90

Volume

415.18K

Volume415.18K

52 Week high

$234.51

52 Week high$234.51

52 Week low

$117.58

52 Week low$117.58

Analyst ratings

62%

of 26 ratings

Buy

61.5%

Hold

34.6%

Sell

3.8%

ALNY Earnings

-$2.03

-$1.79

-$1.54

-$1.30

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

-$1.62 per share

Estimated-$1.62 per share

Actual

-$2.03 per share

Actual-$2.03 per share

Replay Earnings Call